TFL Gallery / t-ae-overview

AET01 · Table

Overview of Treatment-Emergent Adverse Events

Subject counts for any AE, related AEs, serious AEs, and AEs leading to discontinuation or death.

Slug
t-ae-overview
Regulatory ID
AET01
Type
Table
E3 position
§14.3.1
Status
evidenced
Current iteration
v002
Datasets
adae, adsl
Evidence
7/7 passing
Requirements
DSP-AE-001 DSP-AE-002 DSP-AE-003 DSP-AE-004 DSP-AE-005 DSP-ALL-001 DSP-ALL-002 DSP-DEMO-001 DSP-DEMO-002 DSP-DISP-001 DSP-DISP-002 DSP-EXP-001 DSP-EXP-002 DSP-SAE-001

Generated by the same pipeline run that wrote the ARD and the HTML above, from the same rendered cells; the short hash is the manifest's record of the file.

t-ae-overview · post_text variant · study CDISCPILOT01 · data cut-off 2014-07-01

Overview of Treatment-Emergent Adverse Events
Study CDISCPILOT01 — Safety Analysis Set
Placebo (N=86) Xanomeline Low Dose (N=96) Xanomeline High Dose (N=72) Total (N=254)
Adverse events
   Number of events 281 427 414 1122
   Subjects with ≥1 adverse event 65 (75.6%) 84 (87.5%) 68 (94.4%) 217 (85.4%)
   Subjects with a serious adverse event 0 (0.0%) 2 (2.1%) 1 (1.4%) 3 (1.2%)
   Subjects with a fatal adverse event 2 (2.3%) 1 (1.0%) 0 (0.0%) 3 (1.2%)
   Subjects with a related adverse event 43 (50.0%) 77 (80.2%) 64 (88.9%) 184 (72.4%)
Subjects by severity, n (%)
   Mild 58 (67.4%) 64 (66.7%) 64 (88.9%) 186 (73.2%)
   Moderate 25 (29.1%) 58 (60.4%) 46 (63.9%) 129 (50.8%)
   Severe 5 (5.8%) 16 (16.7%) 8 (11.1%) 29 (11.4%)
A treatment-emergent adverse event is an event with TRTEMFL = 'Y'.
Percentages are based on the number of subjects in the safety analysis set for each treatment group.
Subjects reporting more than one event are counted once in each row they qualify for; severity rows count subjects with at least one event of that severity and therefore do not sum to the number of subjects with any event.
Source: adae, adsl (pharmaverseadam). Data cut-off: 2014-07-01.
open.csr display t-ae-overview (post_text variant); generated from the committed ARD.

Rendered from outputs/t-ae-overview/v002/table.html.

Every iteration is kept: outputs/t-ae-overview/vNNN/ holds the spec snapshot, the ARD, the rendered output, and a manifest recording who regenerated it, why, and from which commit.